| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 82, 70-76, Copyright © 1981 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
DE Williams, PC Pairolero, CS Davis, PE Bernatz, WS Payne, WF Taylor, MA Uhlenhopp and RS Fontana
When the TNM staging system of the American Joint Committee (AJC) for
Cancer Staging and End-Results Reporting was applied to 3,912 patients seen
during a 6 year period at the Mayo Clinic, 624 (16%) fulfilled the criteria
for postsurgical pathological Stage I non-small cell bronchogenic
carcinoma. Of these 624 patients, 129 were excluded from further survival
analysis for various reasons. The remaining 495 consisted of two groups:
350 patients who were enrolled within 30 days into a prospective
postoperative 4 monthly follow-up program and 145 patients who were
enrolled later or were followed less frequently. Because no significant
difference was noted in survival rates between these groups, data were
pooled. Of the combined group of 495 patients, 84% survived lung cancer for
2 years and 69% of 5 years (actuarial estimation). The survival of patients
classified T1 N0 M0 (91% alive at 2 years and 80% at 5 years) is so good
that it seems unlikely that adjuvant therapy in this group could
demonstrate improved survival. In addition to TNM classification, age at
operation, sex, and extent of operation were important determinants of
survival.
ARTICLES
Survival of patients surgically treated for stage I lung cancer
This article has been cited by other articles:
|
|
 |
|
  M. Y. Chang, S. J. Mentzer, Y. L. Colson, P. A. Linden, M. T. Jaklitsch, S. R. Lipsitz, and D. J. Sugarbaker Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 850 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Simon, N. Moreno, R. Penalver, G. Gonzalez, E. Alvarez-Fernandez, F. Gonzalez-Aragoneses, and Bronchogenic Carcinoma Cooperative Group of the Sp The Side of Pneumonectomy Influences Long-Term Survival in Stage I and II Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 952 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Kim, J. G. Lee, C. Y. Lee, I.-k. Park, and K. Y. Chung Long-term Survival Following Pneumonectomy for Non-Small Cell Lung Cancer: Clinical Implications for Follow-up Care Chest, July 1, 2007; 132(1): 178 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Trousse, F. Barlesi, A. Loundou, A. M. Tasei, C. Doddoli, R. Giudicelli, P. Astoul, P. Fuentes, and P. Thomas Synchronous multiple primary lung cancer: An increasing clinical occurrence requiring multidisciplinary management J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1193 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kobayashi, H. Kubo, T. Suzuki, K. Ishizawa, M. Yamada, M. He, Y. Yamamoto, H. Yamamoto, H. Sasano, H. Sasaki, et al. Endogenous Secretory Receptor for Advanced Glycation End Products in Non-Small Cell Lung Carcinoma Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 184 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Riquet, C. Foucault, P. Berna, J. Assouad, A. Dujon, and C. Danel Prognostic Value of Histology in Resected Lung Cancer With Emphasis on the Relevance of the Adenocarcinoma Subtyping Ann. Thorac. Surg., June 1, 2006; 81(6): 1988 - 1995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Guo, Y. Ma, R. Ward, V. Castranova, X. Shi, and Y. Qian Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma. Clin. Cancer Res., June 1, 2006; 12(11): 3344 - 3354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Ganti and J. L. Mulshine Lung cancer screening. Oncologist, May 1, 2006; 11(5): 481 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Wisnivesky, T. McGinn, C. Henschke, P. Hebert, M. C. Iannuzzi, and E. A. Halm Ethnic Disparities in the Treatment of Stage I Non-Small Cell Lung Cancer Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1158 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Davies, S. Ghosh, D. Hopkinson, R. Vaughan, and G. Rocco Solitary pulmonary nodules: pathological outcome of 150 consecutively resected lesions Interactive CardioVascular and Thoracic Surgery, February 1, 2005; 4(1): 18 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Barnes The Changing Face of Lung Cancer Chest, December 1, 2004; 126(6): 1718 - 1721. [Full Text] [PDF]
|
|
|
|
|
|
G. Roviaro, F. Varoli, C. Vergani, O. Nucca, M. Maciocco, and F. Grignani Long-term Survival After Videothoracoscopic Lobectomy for Stage I Lung Cancer Chest, September 1, 2004; 126(3): 725 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ren, X. Tang, J. J. Lee, L. Feng, A. D. Everett, W. K. Hong, F. R. Khuri, and L. Mao Expression of Hepatoma-Derived Growth Factor Is a Strong Prognostic Predictor for Patients With Early-Stage Non-Small-Cell Lung Cancer J. Clin. Oncol., August 15, 2004; 22(16): 3230 - 3237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alifano, G. Benedetti, and R. Trisolini Can Low-Molecular-Weight Heparin Improve the Outcome of Patients With Operable Non-Small Cell Lung Cancer?: An Urgent Call for Research Chest, August 1, 2004; 126(2): 601 - 607. [Full Text] [PDF]
|
|
|
|
|
|
T. Iizasa, M. Suzuki, K. Yasufuku, A. Iyoda, M. Otsuji, S. Yoshida, Y. Sekine, K. Shibuya, Y. Saitoh, K. Hiroshima, et al. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma Ann. Thorac. Surg., June 1, 2004; 77(6): 1896 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Chen, T. G Gharib, H. Wang, C.-C. Huang, R. Kuick, D. G. Thomas, K. A. Shedden, D. E. Misek, J. M. G. Taylor, T. J. Giordano, et al. Protein profiles associated with survival in lung adenocarcinoma PNAS, November 11, 2003; 100(23): 13537 - 13542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Alexiou, D. Beggs, P. Onyeaka, K. Kotidis, S. Ghosh, L. Beggs, D. N. Hopkinson, J. P. Duffy, W. E. Morgan, and G. Rocco Pneumonectomy for Stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival Ann. Thorac. Surg., October 1, 2003; 76(4): 1023 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Refaely, S. Sadetzki, A. Chetrit, D. A. Simansky, M. Paley, B. Modan, and A. Yellin The sequence of vessel interruption during lobectomy for non-small cell lung cancer: Is it indeed important? J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1313 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ichinose, K. Genka, T. Koike, H. Kato, Y. Watanabe, T. Mori, S. Iioka, A. Sakuma, and M. Ohta Randomized Double-Blind Placebo-Controlled Trial of Bestatin in Patients With Resected Stage I Squamous-Cell Lung Carcinoma J Natl Cancer Inst, April 16, 2003; 95(8): 605 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Rena, E. Papalia, E. Ruffini, C. Casadio, P. L. Filosso, A. Oliaro, and G. Maggi Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 409 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Miller, C. M. Rowland, C. Deschamps, M. S. Allen, V. F. Trastek, and P. C. Pairolero Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Ann. Thorac. Surg., May 1, 2002; 73(5): 1545 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rena, A. Oliaro, A. Cavallo, P. L. Filosso, G. Donati, P. Di Marzio, G. Maggi, and E. Ruffini Stage I non-small cell lung carcinoma: really an early stage? Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 514 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Alexiou, C.V. P. Onyeaka, D. Beggs, R. Akar, L. Beggs, F. D. Salama, J. P. Duffy, and W. E. Morgan Do women live longer following lung resection for carcinoma? Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 319 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Deslauriers Current surgical treatment of nonsmall cell lung cancer 2001 Eur. Respir. J., February 1, 2002; 19(35_suppl): 61S - 70s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Naruke, R. Tsuchiya, H. Kondo, and H. Asamura Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience Ann. Thorac. Surg., June 1, 2001; 71(6): 1759 - 1764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Khuri, H. Wu, J. J. Lee, B. L. Kemp, R. Lotan, S. M. Lippman, L. Feng, W. K. Hong, and X.-C. Xu Cyclooxygenase-2 Overexpression Is a Marker of Poor Prognosis in Stage I Non-Small Cell Lung Cancer Clin. Cancer Res., April 1, 2001; 7(4): 861 - 867. [Abstract] [Full Text]
|
|
|
|
|
|
O. S. Breathnach, D. J. Kwiatkowski, D. M. Finkelstein, J. Godleski, D. J. Sugarbaker, B. E. Johnson, and S. Mentzer Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0042 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Tang, F. R. Khuri, J. J. Lee, B. L. Kemp, D. Liu, W. K. Hong, and L. Mao Hypermethylation of the Death-Associated Protein (DAP) Kinase Promoter and Aggressiveness in Stage I Non-Small-Cell Lung Cancer J Natl Cancer Inst, September 20, 2000; 92(18): 1511 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. OST and A. FEIN Evaluation and Management of the Solitary Pulmonary Nodule Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 782 - 787. [Full Text]
|
|
|
|
|
|
F. R. Khuri, R. Lotan, B. L. Kemp, S. M. Lippman, H. Wu, L. Feng, J. J. Lee, C. S. Cooksley, B. Parr, E. Chang, et al. Retinoic Acid Receptor-Beta as a Prognostic Indicator in Stage I Non-Small-Cell Lung Cancer J. Clin. Oncol., August 15, 2000; 18(15): 2798 - 2804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Soria, S. J. Jang, F. R. Khuri, K. Hassan, D. Liu, W. K. Hong, and L. Mao Overexpression of Cyclin B1 in Early-Stage Non-Small Cell Lung Cancer and Its Clinical Implication Cancer Res., August 1, 2000; 60(15): 4000 - 4004. [Abstract] [Full Text]
|
|
|
|
|
|
J. Deslauriers and J. Gregoire Surgical Therapy of Early Non-Small Cell Lung Cancer Chest, April 1, 2000; 117(4_suppl_1): 104S - 109S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wagner Jr Postoperative Adjuvant Therapy for Patients With Resected Non-Small Cell Lung Cancer: Still Controversial After all These Years Chest, April 1, 2000; 117(4_suppl_1): 110S - 118S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Ferguson and T. Karrison DOES PNEUMONECTOMY FOR LUNG CANCER ADVERSELY INFLUENCE LONG-TERM SURVIVAL? J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 440 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Herbst, S. Yano, H. Kuniyasu, F. R. Khuri, C. D. Bucana, F. Guo, D. Liu, B. Kemp, J. J. Lee, W. K. Hong, et al. Differential Expression of E-cadherin and Type IV Collagenase Genes Predicts Outcome in Patients with Stage I Non-Small Cell Lung Carcinoma Clin. Cancer Res., March 1, 2000; 6(3): 790 - 797. [Abstract] [Full Text]
|
|
|
|
|
|
S. Kosuda, K. Ichihara, M. Watanabe, H. Kobayashi, and S. Kusano Decision-Tree Sensitivity Analysis for Cost-Effectiveness of Chest 2-Fluoro-2-D-[18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Pulmonary Nodules (Non-small Cell Lung Carcinoma) in Japan Chest, February 1, 2000; 117(2): 346 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Ferguson, J. Wang, P. C. Hoffman, D. J. Haraf, J. Olak, G. A. Masters, and E. E. Vokes Sex-associated differences in survival of patients undergoing resection for lung cancer Ann. Thorac. Surg., January 1, 2000; 69(1): 245 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fujisawa, T. Iizasa, Y. Saitoh, Y. Sekine, S.-i. Motohashi, T. Yasukawa, K. Shibuya, K. Hiroshima, and H. Ohwada Smoking Before Surgery Predicts Poor Long-Term Survival in Patients With Stage I Non-Small-Cell Lung Carcinomas J. Clin. Oncol., July 1, 1999; 17(7): 2086 - 2086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Younes, J. L. Gross, and D. Deheinzelin Follow-up in Lung Cancer: How Often and for What Purpose? Chest, June 1, 1999; 115(6): 1494 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tomizawa, J.-i. Adachi, T. Kohno, K. Hamada, R. Saito, M. Noguchi, Y. Matsuno, S. Hirohashi, N. Yamaguchi, and J. Yokota Prognostic Significance of Allelic Imbalances on Chromosome 9p in Stage I Non-Small Cell Lung Carcinoma Clin. Cancer Res., May 1, 1999; 5(5): 1139 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Leong, C. M. Rocha Lima, C. A. Sherman, and M. R. Green The 1997 International Staging System for Non-Small Cell Lung Cancer: Have All the Issues Been Addressed? Chest, January 1, 1999; 115(1): 242 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. van Velzen, R. J. Snijder, A. B. de la Riviere, H. R. J. Elbers, and J. M. M. van den Bosch Lymph Node Type as a Prognostic Factor for Survival in T2 N1 M0 Non-Small Cell Lung Carcinoma Ann. Thorac. Surg., May 1, 1997; 63(5): 1436 - 1440. [Abstract] [Full Text]
|
|
|
|
|
|
K. S. Virgo, K. S. Naunheim, L. W. McKirgan, M. E. Kissling, J. C. Lin, and F. E. Johnson COST OF PATIENT FOLLOW-UP AFTER POTENTIALLY CURATIVE LUNG CANCER TREATMENT J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 356 - 363. [Abstract] [Full Text]
|
|
|
|
|
|
H. Asamura, H. Nakayama, H. Kondo, R. Tsuchiya, Y. Shimosato, and T. Naruke LYMPH NODE INVOLVEMENT, RECURRENCE, AND PROGNOSIS IN RESECTED SMALL, PERIPHERAL, NON-SMALL-CELL LUNG CARCINOMAS: ARE THESE CARCINOMAS CANDIDATES FOR VIDEO-ASSISTED LOBECTOMY? J. Thorac. Cardiovasc. Surg., June 1, 1996; 111(6): 1125 - 1134. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Nesbitt, J. B. Putnam Jr, G. L. Walsh, J. A. Roth, and C. F. Mountain Survival in Early-Stage Non--Small Cell Lung Cancer Ann. Thorac. Surg., August 1, 1995; 60(2): 466 - 472. [Abstract] [Full Text]
|
|
|
|
|
|
T. Yano, H. Yokoyama, T. Inoue, H. Asoh, K. Tayama, and Y. Ichinose Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lungSignificance of N1 level: lobar or hilar nodes J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1398 - 1402. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Springer T and Tn, general carcinoma autoantigens Science, June 15, 1984; 224(4654): 1198 - 1206. [Abstract] [PDF]
|
|
|
|
 |
|
 S. V. Moroff and S. G. Pauker What To Do When the Patient Outlives the Literature, or DEALE-ing with a Full Deck Med Decis Making, January 1, 1983; 3(3): 313 - 338. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
